IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — AEMD

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q3 2023Q1 2023Q3 2022Q2 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents6.965.853.774.836.869.077.9710.1817.5012.9020.4819.6012.13--25.17
Accounts Receivable----------------0.000.110.130.110.110.110.13
Total Current Assets7.146.254.054.977.149.558.2510.4918.1713.3121.2120.5012.3214.7525.55
Property, Plant & Equipment0.430.510.590.760.840.931.111.201.211.280.251.140.170.150.19
Intangible Assets0.000.000.000.000.000.000.000.000.000.000.000.000.060.060.06
Total Non-current Assets*0.921.071.261.561.711.862.192.342.552.490.712.540.350.300.32
Total Assets8.067.325.316.538.8511.4210.4412.8320.7215.8021.9223.0512.6715.0625.87
Accounts Payable0.470.570.570.610.921.070.690.680.230.840.230.360.180.310.24
Total Current Liabilities1.261.401.631.772.332.132.101.712.441.821.072.101.241.491.13
Total Non-current Liabilities*0.090.170.260.420.500.570.720.801.010.870.291.080.000.000.11
Total Liabilities1.341.581.882.192.832.702.832.513.452.691.363.181.241.491.24
Retained Earnings(173.22)(171.20)(169.72)(161.70)(159.95)(157.14)(152.14)(148.68)(139.89)(145.64)(126.54)(137.04)(117.65)(115.21)(122.01)
Total Stockholder Equity6.715.753.424.336.028.717.6110.3217.2813.1120.7019.8711.5713.7024.87

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q4 2021Q3 2021Q2 2021
Total Revenue------------------0.00--0.570.000.000.010.020.000.030.620.00
Research & Development0.560.530.290.521.300.240.260.410.640.590.630.620.560.680.940.350.850.720.460.51
Selling, General & Admin0.700.740.520.740.720.820.960.750.760.980.850.831.071.311.031.111.550.570.920.55
Total Operating Expenses1.932.061.511.792.001.812.902.622.493.573.183.052.853.413.802.553.672.303.071.77
Operating Income(1.93)(2.06)(1.51)(1.79)(2.00)(1.81)(2.90)(2.62)(2.49)(3.57)(3.18)(2.48)(2.85)(3.41)(3.79)(2.53)(3.67)(2.26)(2.44)(1.77)
Interest Expense----------------------------------------
Net Income(1.88)(2.02)(1.49)(1.76)(6.25)(1.75)(2.81)(2.57)(2.43)(3.47)(3.03)(2.47)(2.85)(3.28)(3.78)(6.64)(2.01)(2.26)(2.44)(1.77)
Basic EPS(3.57)(2.45)(3.74)(0.85)(7.91)(0.13)(0.20)(0.34)(0.91)(1.37)(1.22)(0.11)(0.12)(0.14)----(0.18)------
Diluted EPS(3.57)(2.45)(3.74)(0.85)(7.91)(0.13)(0.20)(0.34)(0.91)(1.37)(1.22)(0.11)(0.12)(0.14)----(0.18)------

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q3 2023Q1 2023Q4 2022Q3 2022Q2 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(1.75)(1.87)(1.66)(1.71)(1.67)(2.01)(2.21)(1.75)(2.57)(2.38)(5.19)(2.95)(7.56)(2.48)(3.10)(6.67)(5.61)(2.24)(2.20)(0.26)
Capital Expenditures--0.00-----0.000.000.000.000.000.010.240.010.930.230.210.140.780.010.030.02
Free Cash Flow*--(1.88)----(1.67)(2.01)(2.21)(1.75)(2.57)(2.39)(5.42)(2.96)(8.49)(2.71)(3.31)(6.80)(6.39)(2.24)(2.23)(0.28)
Investing Cash Flow-0.00-0.00----0.00-0.000.000.00-0.00(0.01)(0.24)(0.01)(0.93)(0.23)(0.21)0.64(0.78)(0.01)(0.03)0.02
Financing Cash Flow(0.20)2.983.74(0.01)2.36(0.01)-0.005.380.040.181.07-0.008.921.08(0.01)17.388.92(0.03)(0.07)(10.20)

* Derived from reported values